Correlation Between Enanta Pharmaceuticals and Talphera
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Talphera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Talphera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Talphera, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Talphera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Talphera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Talphera.
Diversification Opportunities for Enanta Pharmaceuticals and Talphera
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enanta and Talphera is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Talphera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talphera and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Talphera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talphera has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Talphera go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Talphera
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Talphera. But the stock apears to be less risky and, when comparing its historical volatility, Enanta Pharmaceuticals is 2.59 times less risky than Talphera. The stock trades about -0.44 of its potential returns per unit of risk. The Talphera is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 89.00 in Talphera on September 4, 2024 and sell it today you would lose (12.00) from holding Talphera or give up 13.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Talphera
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Talphera |
Enanta Pharmaceuticals and Talphera Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Talphera
The main advantage of trading using opposite Enanta Pharmaceuticals and Talphera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Talphera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talphera will offset losses from the drop in Talphera's long position.| Enanta Pharmaceuticals vs. Candel Therapeutics | Enanta Pharmaceuticals vs. Cingulate Warrants | Enanta Pharmaceuticals vs. Unicycive Therapeutics | Enanta Pharmaceuticals vs. Cardio Diagnostics Holdings |
| Talphera vs. Crinetics Pharmaceuticals | Talphera vs. Enanta Pharmaceuticals | Talphera vs. Amicus Therapeutics | Talphera vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |